SWK Holdings Corp
NASDAQ:SWKH
SWK Holdings Corp
Pre-Tax Income
SWK Holdings Corp
Pre-Tax Income Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Pre-Tax Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
S
|
SWK Holdings Corp
NASDAQ:SWKH
|
Pre-Tax Income
$18.4m
|
CAGR 3-Years
-18%
|
CAGR 5-Years
2%
|
CAGR 10-Years
3%
|
|
|
LM Funding America Inc
NASDAQ:LMFA
|
Pre-Tax Income
-$9m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-42%
|
CAGR 10-Years
N/A
|
|
|
A-Mark Precious Metals Inc
NASDAQ:AMRK
|
Pre-Tax Income
$58.6m
|
CAGR 3-Years
-36%
|
CAGR 5-Years
88%
|
CAGR 10-Years
19%
|
|
|
FlexShopper Inc
NASDAQ:FPAY
|
Pre-Tax Income
$1.3m
|
CAGR 3-Years
-35%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
California First Leasing Corp
OTC:CFNB
|
Pre-Tax Income
$46.6m
|
CAGR 3-Years
0%
|
CAGR 5-Years
38%
|
CAGR 10-Years
N/A
|
|
|
S
|
Standard Premium Finance Holdings Inc
OTC:SPFX
|
Pre-Tax Income
$712.9k
|
CAGR 3-Years
-10%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
SWK Holdings Corp
Glance View
SWK Holdings Corp. is engaged in the business of financial and asset management in the field of pharmaceutical. The company is headquartered in Dallas, Texas and currently employs 35 full-time employees. The firm is focused on providing various capital solutions to a range of life science companies, institutions and inventors. The firm operates through two segments: Finance Receivables and Pharmaceutical Development. Its Finance Receivables segment is primarily focused on monetizing cash flow streams derived from commercial-stage products and related intellectual property through royalty purchases and financings, as well as through the creation of synthetic revenue interests in commercialized products. In addition, through its wholly owned subsidiary, SWK Advisors LLC, it provides non-discretionary investment advisory services to institutional clients in separately managed accounts to similarly invest in life science finance. Through its subsidiary, Enteris BioPharma, Inc., its Pharmaceutical Development segment offers formulation solutions built around its oral drug delivery technology, the Peptelligence platform.
See Also
What is SWK Holdings Corp's Pre-Tax Income?
Pre-Tax Income
18.4m
USD
Based on the financial report for Dec 31, 2024, SWK Holdings Corp's Pre-Tax Income amounts to 18.4m USD.
What is SWK Holdings Corp's Pre-Tax Income growth rate?
Pre-Tax Income CAGR 10Y
3%
Over the last year, the Pre-Tax Income growth was 26%. The average annual Pre-Tax Income growth rates for SWK Holdings Corp have been -18% over the past three years , 2% over the past five years , and 3% over the past ten years .
You don't have any saved screeners yet